August 2016

Recently, CMS Administrator Andy Slavitt and FDA Commissioner Dr. Robert Califf wrote a joint letter to Gary Beatty, Chair of the…

The DOJ and FDA are starting to back off prosecuting cases involving just off-label claims, after making several unsuccessful…

Six executives from the South Korean unit of Novartis have been indicted by prosecutors for paying rebates to doctors in return…

In early July of this year, the Railroad Retirement Board (RRB) became the first federal agency to implement the mandatory…

On August 12, 2016, the Health Resources and Services Administration (HRSA) published a proposed rule: “340B Drug Pricing Program;…

The United States Supreme Court, in recent decision in Universal Health Services, Inc. v. United States ex rel. Escobar…

Three of the 21 participants in CMS’ newest accountable care organizations program, the Next Generation ACOs, have withdrawn since…

Richard Kusserow served as Health and Human Services Inspector General from 1981 to 1992. In this article, he discusses the…

As we previously covered, in July CMS released its annual proposed updates to the Physician Fee Schedule. There are a number of…

In early July 2016, a three-judge panel of the Federal Circuit Court of Appeals issued a unanimous decision in Amgen v. Apotex…